Restasis Ophthalmic Emulsion

Restasis ophthalmic emulsion is a prescription eye medication primarily used for the treatment of chronic dry eye disease, where tear production is reduced due to ocular inflammation. It contains cyclosporine, an immunomodulatory agent that helps address the underlying inflammatory cause of dry eyes, supporting improved natural tear production with consistent use under medical supervision.

This ophthalmic emulsion is designed for long-term therapy and is typically administered twice daily as directed by an eye care professional. Restasis works gradually, helping restore tear balance over time rather than providing immediate lubrication alone. It is well regarded for its targeted anti-inflammatory action within the eye and is commonly recommended for patients with moderate to severe dry eye conditions.

Restasis Ophthalmic Emulsion is a trusted product widely prescribed for dry eye management and is distributed through regulated pharmaceutical channels to ensure safety, quality, and therapeutic reliability. It is formulated according to recognized quality standards to support consistent clinical performance. Eye care specialists frequently include this medication as part of comprehensive, long-term dry eye treatment plans.

Product Features

• Clinically proven for chronic dry eye treatment
• Targets inflammation affecting tear production
• Supports increased natural tear secretion
• Suitable for long-term ophthalmic use
• Sterile ophthalmic emulsion formulation

How It Helps

• Reduces ocular surface inflammation
• Improves natural tear production
• Relieves persistent dry eye symptoms
• Supports long-term eye surface health